A purple and pink letter v on a white background.
March 7, 2019

What Is NeoGraft® and How Can It Grow Your Business?

According to the International Society of Hair Restoration Surgery (ISHRS) 2017 Practice Census, more than 635,000 hair restoration procedures were performed in 2016 alone. That’s a 60% increase in total hair restoration procedures over 2014, which was the last year the census was performed. In addition, there was a 67% increase in surgical procedures. The level of demand for hair restoration shows steady growth, particularly over the last couple of years. Hair rejuvenation treatments are a lucrative market for medical aesthetic professionals. While there are a range of surgical and non-surgical hair restoration procedures in the market, NeoGraft® is a standout. Discover what sets NeoGraft® apart and how this could benefit your medical aesthetics business.

What Is NeoGraft®?

Hair restoration procedures can generally be divided into two methods: follicular unit transplantation (FUT) and follicular unit extraction (FUE). Both methods remove hair follicles from the donor area along the back and side of the head. The main difference between the two processes is that FUT procedures use a scalpel to surgically remove a strip of hair from the back of the scalp. It is then divided into follicular units that are implanted in the recipient areas. In comparison, typical FUE procedures extract hair follicles directly from the scalp in their naturally-occurring groups, generally containing one to three hairs, without having to remove a strip from the scalp. The grafts are sorted by the number of hairs they each contain so that when they are implanted, a natural feathered appearance is obtained. The grafts are also implanted at the natural angle that they would grow in the scalp.

Although FUT can be effective, it is a much more invasive procedure, which results in a linear scar with more discomfort during the post-operative recovery. In comparison, FUE is minimally invasive, not requiring donor-site suture removal and resulting in a shorter recovery time.

What Makes NeoGraft® Different?

NeoGraft® hair restoration uses a miniaturized rotary coring device that initially mobilizes the follicular unit, by separating it from the surrounding tissue. Once the graft has been adequately mobilized, gentle pressure is applied to remove it from the scalp, keeping it intact and undamaged. Using a highly ergonomic mechanical system, the NeoGraft® device acts as a natural extension of the operator’s hand. Accurate harvesting of hair follicles while creating and counting recipient sites is a key component of the NeoGraft® device. The device also features an implantation tool that assists with the placement of grafts in created recipient sites. The goal for the patient is to achieve an optimal result with less downtime and with minimal scarring.

How NeoGraft® Can Benefit Your Business

Demand for hair restoration procedures is expected to stand strong with a potential target market of about 80 million Americans —a quarter of the American population—experiencing hereditary hair loss. Add to this number those who experience hair loss due to other causes. Due to the significant opportunity, incorporating NeoGraft® hair restoration into your practice is a clear choice, especially true for those medical aesthetic clinics specializing in aesthetic treatments that focus on hair. NeoGraft® has a well-established, high patient satisfaction rate, which is documented with a lineup of high-quality before-and-after images.

If you are interested in adding NeoGraft® hair restoration to your practice or in learning more about the technology, contact a Venus Concept expert today using the link below.

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.